360Dx
LightNews LightNews
banner
360dx.bsky.social
360Dx
@360dx.bsky.social
53 followers 24 following 2.3K posts
Real-time news on the IVD market from the publishers of GenomeWeb. Read the latest news at 360Dx.com.
Posts Replies Media Videos
360dx.bsky.social
Take a look at our new website. 360Dx has always been a part of GenomeWeb, but now all our stories will be housed on the GenomeWeb site. www.genomeweb.com .
We'll still running the same type of stories on the diagnostics and clinical laboratory spaces. @genomeweb.bsky.social .
www.genomeweb.com
September 3, 2026 at 7:49 PM
360dx.bsky.social
www.genomeweb.com/business-new...
www.genomeweb.com
September 3, 2026 at 6:25 PM
360dx.bsky.social
www.genomeweb.com/diseases/inf...
www.genomeweb.com
September 3, 2026 at 6:25 PM
360dx.bsky.social
www.360dx.com/business-new...
PixCell Medical Inks Canadian Distribution Deal for CBC Analyzer
The distribution deal comes on the heels of the instrument's approval by Health Canada.
www.360dx.com
September 2, 2026 at 2:33 PM
360dx.bsky.social
www.360dx.com/cancer/canac...
Canaccord Genuity Initiates Coverage of CareDx, BillionToOne With Buy Ratings
The bank gave CareDx a price target of $65 per share and BillionToOne of $120 per share,  noting their strong positions in non-oncology markets and recent moves into cancer testing.
www.360dx.com
September 2, 2026 at 2:33 PM
360dx.bsky.social
www.360dx.com/cancer/senti...
Senticell Closes $7M Seed Financing to Advance Liquid Biopsy Platform
The firm's technology uses red blood cell-bound nucleic acids to identify clinically actionable disease signals in oncology.
www.360dx.com
September 1, 2026 at 7:24 PM
360dx.bsky.social
www.360dx.com/cancer/guard...
Guardant Health Shield Test to be Covered by Carelon for Colorectal Cancer Screening
The coverage decision increases the total covered Shield lives ages 45 and older to approximately 90 million.
www.360dx.com
September 1, 2026 at 2:39 PM
360dx.bsky.social
www.360dx.com/cancer/heide...
Heidelberg Epignostix, NHS to Offer Epigenetic Tumor Classification Service to UK Patients
Under the deal, Heidelberg Epignostix will offer its CNS tumor classification assay free of charge for all pediatric patients across England for three years.
www.360dx.com
September 1, 2026 at 2:20 PM
360dx.bsky.social
www.360dx.com/business-new...
GenomeWeb Top 40 Spikes 10 Percent in August, Outpacing Broader Market for Second Consecutive Month
The Dow Jones Industrial Average rose 1 percent month over month, the Nasdaq rose 4 percent, and the Nasdaq Biotech Index rose 10 percent.
www.360dx.com
September 1, 2026 at 2:19 PM
360dx.bsky.social
www.360dx.com/regulatory-n...
Fujirebio Neurological Blood Tests Cleared for Canadian Market
The tests — for neuroaxonal injury and Alzheimer's disease — received CE marking earlier this year.
www.360dx.com
September 1, 2026 at 2:11 PM
360dx.bsky.social
www.360dx.com/business-new...
VedaBio Inks Precommercial Partnership with UCP Merchant Medicine for CRISPR-Based System
VedaBio expects to establish a channel, price point, and clinical benchmarks for its rapid molecular tests in urgent care settings.
www.360dx.com
September 1, 2026 at 2:10 PM
360dx.bsky.social
www.360dx.com/research-fun...
ARPA-H Awards up to $98.5M for AI-Enabled Rare Disease Diagnosis, Discovery, Treatment
The agency awarded teams led by the University of North Carolina, Sage Bionetworks, FDNA, and Probably Genetic to develop AI technologies and large multimodal datasets.
www.360dx.com
September 1, 2026 at 1:17 PM
360dx.bsky.social
www.360dx.com/infectious-d...
European Project Aims to Develop Electrochemiluminescent POC Test for Sepsis, AMR
The effort, called SepTech, will begin on Sept. 1 and run through August 2029, and it picks up from an earlier project called ECLIPSE.
www.360dx.com
August 31, 2026 at 3:50 PM
360dx.bsky.social
www.360dx.com/policy-legis...
Laboratory, Diagnostics, Tools Firms Top $26M in Washington D.C. Lobbying in H1 2026
Key issues included reform of the Protecting Access to Medicare Act (PAMA), reimbursement and coverage for laboratory testing, and federal funding for scientific research.
www.360dx.com
August 31, 2026 at 12:53 PM
360dx.bsky.social
www.360dx.com/business-new...
In Brief This Week: Burning Rock Biotech; Ataraxis AI; European Commission, Altona Diagnostics
News items for the week of Aug. 24, 2026.
www.360dx.com
August 31, 2026 at 12:52 PM
360dx.bsky.social
www.nytimes.com/2026/08/27/w...
Celebrities Are Raving About Full-Body Scans. Doctors Urge Caution
The scans are touted as a way to control your health. But researchers say healthy people don’t need them and they can lead to more harm than benefit.
www.nytimes.com
August 28, 2026 at 4:38 PM
360dx.bsky.social
www.360dx.com/business-new...
In Brief This Week: Burning Rock Biotech; Ataraxis AI; European Commission, Altona Diagnostics
News items for the week of Aug. 24, 2026.
www.360dx.com
August 28, 2026 at 12:43 PM
360dx.bsky.social
www.360dx.com/research-fun...
Readily Diagnostics Wins $970K Gates Foundation Grant for STI Testing
The funding will support a point-of-care test to detect the pathogens causing chlamydia, trichomoniasis, and gonorrhea as well as genetic resistance.
www.360dx.com
August 28, 2026 at 12:31 PM
360dx.bsky.social
www.360dx.com/cancer/start...
Startup Hypermelt Aims to Improve Early Cancer Detection With Microfluidics, Thermal Analysis
The firm's technology combines microfluidic sample digitization with thermal-optical analysis to improve sensitivity.
www.360dx.com
August 28, 2026 at 12:30 PM
360dx.bsky.social
www.360dx.com/research-fun...
Readily Diagnostics Wins $970K Gates Foundation Grant for STI Testing
The funding will support a point-of-care test to detect the pathogens causing chlamydia, trichomoniasis, and gonorrhea as well as genetic resistance.
www.360dx.com
August 27, 2026 at 8:03 PM
360dx.bsky.social
www.360dx.com/business-new...
Interspace Biosciences to Execute 1-for-5 Reverse Stock Split
The reverse split is intended to bring the company into compliance with the minimum bid price requirement for listing on the Nasdaq.
www.360dx.com
August 27, 2026 at 3:50 PM
360dx.bsky.social
www.360dx.com/cancer/neoge...
NeoGenomics MRD Test Receives Expanded CMS Coverage for Immunotherapy Monitoring
The ctDNA test is now covered for monitoring response to immune checkpoint inhibitor therapy in patients with late-stage solid tumors.
www.360dx.com
August 27, 2026 at 2:14 PM
360dx.bsky.social
www.360dx.com/clinical-lab...
Roche Mass Spec System Could Drive Esoteric Test Development, Industry Consolidation
Some observers suggest incumbent vendors will adapt to the new competition by using their instruments for higher-value assays, though others anticipate testing consolidation.
www.360dx.com
August 27, 2026 at 1:57 PM
360dx.bsky.social
www.360dx.com/cancer/roche...
Roche Nabs FDA Approval for CDx With Ziihera in Gastroesophageal Cancer
The tests are approved to assess HER2-positive status in metastatic gastroesophageal adenocarcinoma patients.
www.360dx.com
August 27, 2026 at 1:10 PM
360dx.bsky.social
www.360dx.com/point-care-t...
Untapped Opportunities in $50B Rural Healthcare Funding Called Out at Next-Gen Dx Summit
The Rural Health Transformation Program may be an unprecedented boon for healthcare, but diagnostics developers are running the risk of missing out.
www.360dx.com
August 27, 2026 at 1:10 PM